Vargas-Gonzalez A, Canto-Lara S B, Damian-Centeno A G, Andrade-Narvaez F J
Laboratorio de Immunología, Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán, Mérida, México.
Am J Trop Med Hyg. 1999 Dec;61(6):960-3. doi: 10.4269/ajtmh.1999.61.960.
Cutaneous leishmaniasis, known as chiclero's ulcer in southeastern Mexico, is characterized by a predominantly single, painless, ulcerated lesion, without lymphangitis or adenopathy. When located on the ear, it tends to become chronic, causing destruction of the pinna and disfigurement. It is caused predominantly by Leishmania (L.) mexicana. Although pentavalent antimonials (Sb5+) are the mainstay of leishmanial therapy and have been used for more than 50 years, dosage regimens have been repeatedly modified and the best one has not been fully identified. The main purpose of the present study was to investigate the response of chiclero's ulcer to treatment with meglumine antimoniate. One hundred five patients were treated with meglumine antimoniate at a daily dose of 1 ampule per day (425 mg of Sb5+) until healing. The lesions healed after a mean of 25 days (range = 5-60 days).
皮肤利什曼病在墨西哥东南部被称为“吉氏溃疡”,其特征主要为单个无痛性溃疡病灶,无淋巴管炎或淋巴结病。当位于耳部时,往往会转为慢性,导致耳廓破坏和毁容。该病主要由墨西哥利什曼原虫引起。尽管五价锑(Sb5+)是治疗利什曼病的主要药物,且已使用了50多年,但给药方案多次修改,最佳方案尚未完全确定。本研究的主要目的是调查吉氏溃疡对葡甲胺锑酸盐治疗的反应。105例患者接受葡甲胺锑酸盐治疗,每日剂量为1安瓿(425mg Sb5+),直至痊愈。病灶平均在25天(范围为5 - 60天)后愈合。